Geode Capital Management, LLC Sorrento Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.74 - $1.83 $1.33 Million - $3.29 Million	1,797,652 Added 25.29%	8,905,936 $7.89 Million
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $325,158 - $620,170	215,337 Added 3.12%	7,108,284 $11.2 Million
Q2 2022 Aug 12, 2022	BUY	$1.24 - $2.33 $2.36 Million - $4.44 Million	1,906,514 Added 38.23%	6,892,947 $13.9 Million
Q1 2022 May 13, 2022	SELL	$2.0 - $4.9 $629,646 - $1.54 Million	-314,823 Reduced 5.94%	4,986,433 $11.6 Million
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.23 $1.12 Million - $1.75 Million	241,923 Added 4.78%	5,301,256 $24.7 Million
Q3 2021 Nov 12, 2021	BUY	$7.41 - $10.99 $4.84 Million - $7.18 Million	653,387 Added 14.83%	5,059,333 $38.6 Million
Q2 2021 Aug 13, 2021	BUY	$6.35 - $10.0 $2.23 Million - $3.52 Million	351,633 Added 8.67%	4,405,946 $42.7 Million
Q1 2021 May 12, 2021	BUY	$7.03 - $16.51 $2.97 Million - $6.98 Million	423,072 Added 11.65%	4,054,313 $33.5 Million
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $2.86 Million - $5.94 Million	497,091 Added 15.86%	3,631,241 $24.8 Million
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $4.3 Million - $13.1 Million	697,029 Added 28.6%	3,134,150 $34.9 Million
Q2 2020 Aug 13, 2020	BUY	$1.73 - $6.76 $1.05 Million - $4.1 Million	606,455 Added 33.13%	2,437,121 $15.3 Million
Q1 2020 May 14, 2020	BUY	$1.57 - $4.76 $189,109 - $573,351	120,452 Added 7.04%	1,830,666 $3.37 Million
Q4 2019 Feb 13, 2020	BUY	$1.45 - $4.17 $219,367 - $630,870	151,288 Added 9.7%	1,710,214 $5.78 Million
Q3 2019 Nov 12, 2019	BUY	$2.05 - $2.69 $208,888 - $274,102	101,897 Added 6.99%	1,558,926 $3.34 Million
Q2 2019 Aug 14, 2019	BUY	$2.67 - $4.38 $337,172 - $553,115	126,282 Added 9.49%	1,457,029 $3.89 Million
Q1 2019 May 14, 2019	BUY	$1.86 - $5.94 $520,552 - $1.66 Million	279,867 Added 26.63%	1,330,747 $6.32 Million
Q4 2018 Feb 13, 2019	BUY	$2.01 - $4.24 $121,122 - $255,502	60,260 Added 6.08%	1,050,880 $2.52 Million
Q3 2018 Nov 13, 2018	BUY	$4.22 - $7.5 $921,234 - $1.64 Million	218,302 Added 28.27%	990,620 $4.36 Million
Q2 2018 Aug 14, 2018	BUY	$4.75 - $8.0 $1.33 Million - $2.24 Million	280,542 Added 57.05%	772,318 $5.56 Million
Q1 2018 May 15, 2018	BUY	$4.5 - $9.95 $140,202 - $310,002	31,156 Added 6.76%	491,776 $2.53 Million
Q3 2017 Nov 14, 2017	BUY	$1.63 - $2.0 $93,945 - $115,270	57,635 Added 14.3%	460,620 $783,000
Q2 2017 Aug 14, 2017	BUY	N/A	402,985	402,985 $805,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.53M

Call Options Held

Put Options Held

B. Riley Securities, Inc. Los Angeles, CA

5.22M
Shares

$1.72 Million
1.01% of portfolio
Swisspartners Ltd. Vaduz, N2

110K
Shares

$36,300
0.12% of portfolio
Kingswood Wealth Advisors, LLC San Diego, CA

65.7K
Shares

$21,664
0.0% of portfolio
Lattice Capital Management, LLC

51.8K
Shares

$17,094
0.02% of portfolio
High Point Advisor Group LLC Downers Grove, IL

22.3K
Shares

$7,342
0.0% of portfolio

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account